RT期刊论文SR电子T1国际ERS / ESICM / ESCMID /阿拉特医院获得性肺炎和呼吸机相关性肺炎的管理方针JF欧洲呼吸杂志JO欧元呼吸杂志FD欧洲呼吸学会SP 1700582 DO 10.1183 / 13993003.00582-2017 VO 50188bet官网地址3 A1托雷斯，安东尼A1尼德曼，迈克尔S A1沙斯特尔，让A1 Ewig，圣地亚哥A1费尔南德斯 - 班德略斯，帕特里夏A1 Hanberger，哈坎A1 Kollef，马林A1李巴斯，布冯A1红月，卡洛斯·M. A1马丁洛埃切斯，伊格纳西奥A1派瓦，J.阿图尔A1读，罗伯特C. A1 Rigau，大卫A1坦西，让弗朗索瓦A1威尔特，托比亚斯A1 Wunderink，理查德YR 2017年UL //www.qdcxjkg.com/content/50/3/1700582.abstract AB The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studies of epidemiology, diagnosis, empiric treatment, response to treatment, new antibiotics or new forms of antibiotic administration and disease prevention have changed old paradigms. In addition, important differences between approaches in Europe and the USA have become apparent.The European Respiratory Society launched a project to develop new international guidelines for HAP and VAP. Other European societies, including the European Society of Intensive Care Medicine and the European Society of Clinical Microbiology and Infectious Diseases, were invited to participate and appointed their representatives. The Latin American Thoracic Association was also invited.A total of 15 experts and two methodologists made up the panel. Three experts from the USA were also invited (Michael S. Niederman, Marin Kollef and Richard Wunderink).Applying the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) methodology, the panel selected seven PICO (population–intervention–comparison–outcome) questions that generated a series of recommendations for HAP/VAP diagnosis, treatment and prevention.ERS/ESICM/ESCMID/ALAT evidence-based recommendations for HAP/VAP diagnosis, treatment and prevention http://ow.ly/dGhv30dAVoa